sulfasalazine has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Excerpt | Relevance | Reference |
---|---|---|
"Clarithromycin was continued a further two months until the patient quit on her own and." | 1.36 | [A cutaneous infection by Mycobacterium chelonae in a patient with rheumatoid arthritis]. ( Azevedo, F; Baudrier, T; Duarte, AF; Ferreira, O; Mota, A; Simões, JS, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferreira, O | 1 |
Duarte, AF | 1 |
Baudrier, T | 1 |
Mota, A | 1 |
Simões, JS | 1 |
Azevedo, F | 1 |
1 other study available for sulfasalazine and Atypical Mycobacterial Infection, Disseminated
Article | Year |
---|---|
[A cutaneous infection by Mycobacterium chelonae in a patient with rheumatoid arthritis].
Topics: Anti-Bacterial Agents; Arthritis, Rheumatoid; Ciprofloxacin; Clarithromycin; Drug Combinations; Fema | 2010 |